Is it safe to proceed with surgery in a patient with elevated preoperative alanine aminotransferase (ALT) and aspartate aminotransferase (AST)?

Delay Surgery and Investigate the Cause of Elevated Transaminases

Surgery should be postponed in this patient until the etiology of these significantly elevated liver enzymes is identified and hepatic function is properly assessed. With ALT 190 U/L (approximately 5-6× upper limit of normal) and AST 247 U/L (approximately 6-7× ULN), this represents moderate hepatocellular injury that requires urgent evaluation before proceeding with elective surgery 1.

Why These Elevations Matter for Surgical Risk

The degree of aminotransferase elevation directly correlates with perioperative morbidity and mortality:

• Elevated preoperative AST is an independent predictor of 30-day postoperative mortality across multiple surgical procedures 2, 3
• In pancreaticoduodenectomy, elevated preoperative AST increased odds of 30-day mortality by 6-fold, with an AST/ALT ratio >0.89 associated with 8-times increased odds of death 2
• Your patient's AST/ALT ratio is 1.3, which exceeds this high-risk threshold
• Even in cardiac surgery, elevated postoperative AST independently predicts both early and late mortality 3

Immediate Preoperative Workup Required

Before any surgical decision, obtain:

Laboratory Assessment

• Repeat ALT, AST, alkaline phosphatase, total and direct bilirubin, albumin, and INR within 2-5 days 4
• Complete blood count with platelets
• Hepatitis panel (HBsAg, anti-HCV, HAV-IgM) 5
• Metabolic panel including glucose and creatinine 6

Clinical Evaluation

• Detailed medication history including over-the-counter drugs, supplements, and herbal products (drug-induced liver injury is a common cause) 1
• Alcohol consumption history (AST:ALT ratio >2 suggests alcoholic liver disease; your patient's ratio of 1.3 is more consistent with NAFLD or other causes) 1
• Symptoms of liver disease: fatigue, nausea, right upper quadrant pain, jaundice 4
• Risk factors for viral hepatitis, metabolic syndrome, autoimmune disease 1

Imaging

• Right upper quadrant ultrasound to assess for steatosis, biliary obstruction, or structural abnormalities 1

Classification and Risk Stratification

Your patient's transaminase elevations are classified as moderate (5-10× ULN for AST, approaching this threshold for ALT) 1. This severity level warrants:

1. Hepatocellular pattern of injury (aminotransferases elevated disproportionately to alkaline phosphatase) 1
2. Common causes to exclude: NAFLD, alcohol-induced liver disease, drug-induced liver injury, viral hepatitis, hemochromatosis 1
3. Less common but critical causes: acute Budd-Chiari syndrome, ischemic hepatitis, autoimmune hepatitis, Wilson disease 1

When Surgery Can Proceed

Surgery may be considered only after:

1. Another etiology is definitively identified (e.g., transient drug effect, resolving viral illness) 4
2. Liver enzymes return to baseline or near-normal levels 4
3. Hepatic synthetic function is confirmed normal (albumin, INR) 5, 7
4. No evidence of advanced liver disease (no ascites, encephalopathy, varices, thrombocytopenia, or prolonged INR) 8, 7

Special Considerations for Surgical Planning

If underlying chronic liver disease is discovered:

• Calculate FIB-4 score to assess fibrosis risk: Age × AST / (Platelet count × √ALT) 6, 8
  • FIB-4 >2.67 indicates high risk for advanced fibrosis requiring hepatology referral 8
• Assess for portal hypertension (platelet count <150,000, splenomegaly on imaging) - a major predictor of post-hepatectomy liver failure and perioperative complications 6
• Consider Child-Pugh classification if cirrhosis suspected 6, 7

Common Pitfalls to Avoid

• Do not proceed with "routine" surgery assuming transaminase elevations are incidental - they independently predict mortality 2, 3
• Do not rely solely on imaging - normal ultrasound does not exclude significant liver disease 1
• Do not assume NAFLD is benign - it can progress to NASH with fibrosis, particularly in patients with diabetes or obesity 1
• Do not prophylactically transfuse or correct INR with fresh frozen plasma without evidence of active bleeding - this does not improve outcomes and may cause harm 7

The bottom line: These enzyme elevations represent active hepatocellular injury of unclear etiology. Proceeding with surgery without investigation places the patient at substantially increased risk of perioperative mortality and complications. A 1-2 week delay for proper evaluation is far safer than accepting this preventable risk.